Nootropic Blends
A handful of nootropic ingredients have modest individual evidence (caffeine plus L-theanine, citicoline, bacopa), but multi-ingredient "brain" blends are rarely tested as sold, usually under-dose the components, and a worrying share of the category has been found spiked with unapproved drugs. The few trials of finished blends are small and single-dose, and the most recent found a blend did no better overall than 150 mg of caffeine.
What the science says
- The blends themselves are almost never tested Limited evidence
Commercial nootropic stacks combine 8-15 ingredients, of which only a few (caffeine, L-theanine, citicoline, bacopa, alpha-GPC) have any human cognitive data. The few trials of finished products are small single-dose crossover studies scored on reaction-time batteries: one found moderate gains over placebo, another found the blend matched but did not beat 150 mg of caffeine.
- Who was studied
- Two crossover trials of 26 healthy adults each: young adults (mean age 24.9, 50% women) given 10 g of a commercial blend, and adults given a blend, 150 mg of caffeine or placebo.
- Result
- Reaction time and accuracy on computer tasks (processing speed, inhibitory control, working memory, flanker, Stroop, sustained attention) 30 to 300 minutes after a single dose.
- Effect size
- Versus placebo the first blend improved response time and accuracy with effect sizes of 0.4-0.6, but not verbal fluency, motivation or anxiety; the second sped flanker and Stroop responses about as much as caffeine, raised blood pressure less, and did not match caffeine on sustained-attention accuracy.
- Limitations
- Single doses, 26 people per trial and results tied to one formulation each, so they say nothing about other products; the newer trial was registered only retrospectively.
- Sources
- [1] [2]
- Caffeine + L-theanine is the one combination with reasonable support Moderate evidence
Roughly 50-100 mg caffeine with 100-200 mg L-theanine improves attention-switching accuracy and vigilance in acute trials, with theanine blunting caffeine-related jitteriness. A 2025 meta-analysis confirmed small-to-moderate effects in the first two hours, but the effects are short-lived and much of the benefit is simply caffeine.
- Who was studied
- 50 randomised trials in healthy participants, 15 of them pooled in meta-analyses, mostly acute crossover studies of theanine with or without caffeine.
- Result
- Reaction time, vigilance, attention switching and mood in the first and second hour after a dose.
- Effect size
- Theanine plus caffeine versus placebo in the second hour: attention-switching accuracy SMD 0.33 (95% CI 0.13 to 0.54) and digit-vigilance accuracy SMD 0.20 (0.02 to 0.38); choice reaction time in the first hour, SMD -0.48 (-1.01 to 0.05), was not significant; theanine alone improved choice reaction time, SMD -0.35 (-0.61 to -0.10).
- Limitations
- Few small trials per pooled outcome with wide confidence intervals, laboratory tasks rather than real-world performance, and the review was partly funded and co-authored by employees of tea companies (Lipton, Unilever).
- Sources
- [3]
- Effects in healthy adults are smaller and less consistent than the labels suggest Limited evidence
Bacopa (300 mg/day standardised extract) shows memory benefits mainly after 8-12 weeks, and a 2026 network meta-analysis in healthy adults found working-memory gains mostly at 600 mg/day or more, far above typical blend doses. Ginkgo showed no effect in healthy people, and in 2024 EFSA rejected a memory claim for citicoline. The category markets impairment-population data to unimpaired customers.
- Who was studied
- Healthy adults: 29 bacopa or ginkgo trials (2,107 participants), 13 ginkgo memory trials (1,132 participants), and the citicoline trials in healthy middle-aged and older adults assessed by EFSA.
- Result
- Memory, attention, executive function and processing speed after weeks to months of daily use.
- Effect size
- High-dose bacopa beat placebo on working memory (SMD 2.03, 95% CI 1.28 to 2.78) with no difference in attention or processing speed; ginkgo effects were close to zero (memory d = -0.04, 95% CI -0.17 to 0.07); EFSA found only one positive citicoline trial (500 mg/day for 12 weeks) and judged cause and effect not established.
- Limitations
- The bacopa effect size is implausibly large for a supplement and rests largely on indirect network comparisons; the ginkgo analysis dates from 2012; none of these trials tested a multi-ingredient blend.
- Sources
- [4] [5] [6]
- Unapproved drugs are commonly found in this category Strong evidence
Analytical testing of cognitive-enhancement supplements has identified unapproved pharmaceuticals — omberacetam (noopept), aniracetam, phenibut, vinpocetine and picamilon — sometimes at doses several times a typical pharmaceutical dose, and often with the actual content differing sharply from the label. A broader review documents that these unauthorised nootropic ingredients are widespread internationally and several are relevant as doping agents.
- Who was studied
- 10 US supplements labelled as containing racetams, analysed by mass spectrometry, plus a review of 50 products sold as nootropics and of international regulations.
- Result
- Presence and amount of unapproved drugs compared with the label.
- Effect size
- Five unapproved drugs were found; one serving could deliver up to 40.6 mg omberacetam (typical drug dose 10 mg), 502 mg aniracetam or 90.1 mg picamilon, up to four times a pharmaceutical dose and as many as 4 unapproved drugs in one product; 75% (9 of 12) of declared quantities were inaccurate.
- Limitations
- The product sample was small and chosen for racetam labels, so it does not estimate how common adulteration is across all brain supplements; the review is descriptive.
- Sources
- [7] [8]
Dosage & safety
How to take it
Interactions
With medications
- cholinesterase inhibitors (donepezil, rivastigmine) and anticholinergic drugs
Huperzine A is itself a cholinesterase inhibitor and either adds to or fights these drugs. do not combine
- benzodiazepines, z-drugs and alcohol
Phenibut is a GABA-B agonist with real dependence and withdrawal risk and adds heavily to sedation. avoid phenibut-containing blends entirely
- antidepressants and other psychiatric medication
Several blend ingredients act on the same neurotransmitter systems, and labels in this category are frequently inaccurate. go through the full ingredient list with your prescriber first
- anticoagulants and antiplatelet drugs
Vinpocetine has antiplatelet activity and is already banned from supplements in several jurisdictions. avoid vinpocetine-containing products
With other supplements
- other caffeine sources
Stimulant blends stack with coffee and pre-workouts. count total daily caffeine
Well-established interactions only — this is not a complete list. Always tell your doctor and pharmacist what you take.
Frequently asked questions
Do nootropic brain supplements work?
Multi-ingredient nootropic blends are rarely tested as sold and usually under-dose their components (limited evidence). A few individual ingredients, such as caffeine with L-theanine, citicoline and bacopa, have modest evidence of their own.
Does caffeine with L-theanine improve focus?
Caffeine plus L-theanine is the one nootropic combination with reasonable support (moderate evidence): roughly 50-100 mg caffeine with 100-200 mg L-theanine improves attention-switching accuracy and reduces distractibility in acute trials. The effects are real but small and short-lived, and much of the benefit is simply the caffeine.
Are nootropic blends safe?
Analytical testing has commonly found unapproved drugs in nootropic supplements, including noopept, aniracetam, phenibut and vinpocetine, sometimes at several times a pharmaceutical dose (strong evidence). Phenibut carries real dependence and withdrawal risk, and the FDA has warned vinpocetine may cause miscarriage or fetal harm, so anyone on psychiatric medication or subject to drug testing should be especially cautious.
How long does bacopa take to work in a nootropic stack?
Bacopa needs 8-12 weeks at 300 mg/day of a standardised extract before judging it, and its memory benefits appear mainly in older adults (limited evidence). Many nootropic blends contain only 100-150 mg bacopa, and bacopa causes nausea and cramping on an empty stomach, so take it with food.
Scientific references
- Acute Effect of a Dietary Multi-Ingredient Nootropic as a Cognitive Enhancer in Young Healthy Adults: A Randomized, Triple-Blinded, Placebo-Controlled, Crossover Trial.
- Comparable improvements in selective, but not sustained, attention in response to a multi-ingredient nootropic formulation when compared with caffeine.
- Effects of Tea (Camellia sinensis) or its Bioactive Compounds l-Theanine or l-Theanine plus Caffeine on Cognition, Sleep, and Mood in Healthy Participants: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
- Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
- 'Citicoline' and support of the memory function: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
- Five Unapproved Drugs Found in Cognitive Enhancement Supplements.
- Unauthorized ingredients in "nootropic" dietary supplements: A review of the history, pharmacology, prevalence, international regulations, and potential as doping agents.
Related in Brain & cognition
- Vitamin B2 (Riboflavin) Moderate evidence
- Choline Moderate evidence
- Magnesium L-Threonate Limited evidence
- Phosphatidylserine Limited evidence
- Lecithin (Phosphatidylcholine) Limited evidence
- Agmatine Sulfate Limited evidence